Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-10-12

Clinical Trial Update: Allogeneic Umbilical Cord Blood Therapy for Stroke [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating allogeneic umbilical cord blood therapy for stroke has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Allogeneic Umbilical Cord Blood Therapy

Snippet

Sponsor: MinYoung Kim, M.D. | Conditions: Stroke | Phase 1 | Status: COMPLETED